Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

• Váldodahkkit: Tangui Barré (Dahkki), Fabrice Carrat (Dahkki), Clémence Ramier (Dahkki), Hélène Fontaine (Dahkki), Vincent Di Beo (Dahkki), Morgane Bureau (Dahkki), Céline Dorival (Dahkki), Dominique Larrey (Dahkki), Elisabeth Delarocque-Astagneau (Dahkki), Philippe Mathurin (Dahkki), Fabienne Marcellin (Dahkki), Ventzislava Petrov-Sanchez (Dahkki), Carole Cagnot (Dahkki), Patrizia Carrieri (Dahkki), Stanislas Pol (Dahkki), Camelia Protopopescu (Dahkki), the ANRS/AFEF Hepather study group (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2022-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated...